3[3]Zaman SN,Melia WM,Johnson RD,Portmann BC,Johnson PJ,Williams R.Risk factors in development of hepatocellular carcinoma in cirrhosis:prospective study of 613 patients.Lancet 1985; 1:1357-1360
4[4]Benvegnu L,Gios M,Boccato S,Alberti A.Natural history of compensated viral cirrhosis:a prospective study on the incidence and hierarchy of major complications.Gut 2004; 53:744-749
5[5]Liaw YF,Tai DI,Chu CM,Lin DY,Sheen IS,Chen TJ,Pao CC.Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis.A prospective study.Gastroenterology 1986; 90:263-267
6[6]Zhang BH,Yang BH,Tang ZY.Randomized controlled trial of screening for hepatocellular carcinoma.J Cancer Res Clin Oncol 2004; 130:417-421
7[7]E1-Serag HB,Mason AC,Key C.Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996in the United States.Hepatology 2001; 33:62-65
8[8]Bruix J,Sherman M,Llovet JM,Beaugrand M,Lencioni R,Burroughs AK,Christensen E,Pagliaro L,Colombo M,Rodes J.EASL panel of rxperts on HCC.Clinical management of hepatocellular carcinoma.Conclusions of the barcelona-2000EASL conference.European sssociation for the dtudy of the liver.J Hepatol 2001; 35:421-430
9[9]Liebman HA,Furie BC,Tong MJ,Blanchard RA,Lo KJ,Lee SD,Coleman MS,Furie B.Des-gamma-carboxy (abnormal)prothrombin as a serum marker of primary hepatocellular carcinoma.N Engl J Med 1984; 310:1427-1431
10[10]Soulier JP,Gozin D,Lefrere JJ.A new method to assay desgamma-carboxyprothrombin.Results obtained in 75 cases of hepatocellular carcinoma.Gastroenterology 1986; 91:1258-1262
2Bashour FN, Teran JC, Mullen KD. Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am J Gastroenterol, 2000, 95:2936-2939.
3Peck-Radosavljevic M, Wichlas M, Zacherl J, et al. Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood, 2000, 95:795-801.
4Cui R, Wang B, Ding H, et al. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma. Chin Med J ( Engl), 2002, 115 : 42- 45.
5Naraki T, Kohno N, Saito H, et al. gamma-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-gamma-carboxy prothrombin. Biochim Biophys Acta, 2002, 1586:287-298.
6Bismuth H, Samuel D, Castaing D, et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg, 1995, 222 : 109-119.
7Rodriguez-Inigo E, Bartolome J, Quiroga JA, et al. Expression of factor Ⅶ in the liver of patients with liver disease: correlations with the disease severity and impairment in the hemostasis. Blood Coagul Fibrinolysis, 2001, 12:193-199.
8Violi F, Ferro D, Basili S, et al. Prognostic value of clotting and fibrinolytic systems in a follow-up of 165 liver cirrhotic patients. CALC Group. Hepatology, 1995, 22:96-100.
9Hollestelle MJ, Geertzen HG, Straatsburg IH, et al. Factor Ⅷ expression in liver disease. Thromb Haemost, 2004, 91:267-275.
10Iwabuchi S, Takatori M, Okabe K. Adequate parameters for the diagnosis of disseminated intravascular coagulation (DIC) in patients with liver diseases. Nippon Rinsho, 1993, 51:67-73.
